Video

Komen NYC Educates Women About Breast Cancer Screening

Author(s):

Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.

Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.

Komen’s Third Annual Patient Navigation Initiative will be held June 25, which will have both lay and nurse navigators to discuss what is and isn’t working in patient navigation in the breast cancer space. The discussion will also include who is funding patient navigation, as it is currently not reimbursable through insurance.

In addition, the Sisters for the Cure event will be held on June 29. “It is our effort to really address the disparities in the African American community,” said Tantawi. “We know that African American women are 40% more likely to die from breast cancer than white women, and that is unacceptable.” This initiative will look into what can be done to ensure that African American women have the same quality and access to care as their white counterparts.

Lastly, the NY Metastatic Breast Cancer Conference will be held Oct. 5 through 6. At this event, “we bring the best researchers from all across the country right to New York (for) patients who wouldn’t have access to those researchers,” said Tantawi. “They don’t go to San Antonio, they can’t come here to ASCO, so let’s bring that information right to them.”

To learn more, visit komennyc.org.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content